To find a protein kinase C (PKC)-independent preconditioning mechanism, hypoxic preconditioning (HP; i.e., 10-min anoxia and 10-min reoxygenation) was applied to isolated rat hearts before 60-min global ischemia. HP led to improved recovery of developed pressure and reduced end-diastolic pressure in the left ventricle during reperfusion. Protection was unaffected by the PKC inhibitor bisindolylmaleimide (BIM; 1 mol/l). It was abolished by the inhibitor of protein phosphatases 1 and 2A cantharidin (20 or 5 mol/l) and partially enhanced by the inhibitor of protein phosphatase 2A okadaic acid (5 nmol/l). In adult rat cardiomyocytes treated with BIM and exposed to 60-min simulated ischemia (anoxia, extracellular pH 6.4), HP led to attenuation of anoxic Na ϩ /Ca 2ϩ overload and of hypercontracture, which developed on reoxygenation. This protection was prevented by treatment with cantharidin but not with okadaic acid. In conclusion, HP exerts PKC-independent protection on ischemic-reperfused rat hearts and cardiomyocytes. Protein phosphatase 1 seems a mediator of this protective mechanism. cellular calcium; heart function; ischemia; reperfusion SEVERAL STUDIES (18,25,32) have demonstrated that protection of the myocardium against ischemia-reperfusion injury caused by a brief preceding ischemia (ischemic preconditioning) is due to the release and accumulation of endogenous mediators, such as adenosine or noradrenaline, during ischemic preconditioning and a subsequent activation of protein kinase C (PKC). There are, however, data (20,23,27) indicating that protection by ischemic preconditioning can also be achieved independent of PKC activation. The mechanism of this PKC-independent protection could not be explained. Brief periods of hypoxia, i.e., hypoxic preconditioning (HP), which do not allow accumulation of ischemic mediators, can also provide protection against ischemia-reperfusion injury (17,19,30,32). Previous studies (14, 26) of isolated hearts demonstrated that protection induced by HP does not involve the activation of adenosine receptors or G i proteins, suggesting a protective signaling different from well-known mechanisms of ischemic preconditioning. A protective role of PKC in HP was suggested for cultured embryonic cardiac myocytes (6, 29), but this was not demonstrated in adult cardiac myocytes or the adult whole heart. In general, the mechanisms of HP-induced protection are still not fully understood. For the present study, we hypothesized that HP leads to protection due to a PKC-independent mechanism. We (1) tested whether protection induced by HP is PKC independent and (3) which other type of signaling is responsible for HPinduced protection. Motivated by reports (2, 3) that inhibitors of these protein phosphatases (PP) can imitate ischemic preconditioning in some experimental models, we focused our study on the role of serine threonine PP1 and PP2A.We used the experimental model of isolated Langendorff-perfused rat hearts exposed to 60 min of global ischemia and 60 min of reperfusion. To test for im...